Evoltra and neutropenia Patient Reports February 13, 2012



Evoltra Side Effects Report #5316485-2
Evoltra side effect was reported by a Health Professional from UNITED KINGDOM on Mar 01, 2007. Male patient, 79 years of age, was diagnosed with acute myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: dermatitis exfoliative, neutropenia. Evoltra dosage: 35 MG QD IV. During the same period patient was treated with MYLOTARG, DAUNORUBICIN, MEROPENEM, TEICOPLANIN, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Evoltra Side Effects Report #6106878-8
Evoltra side effect was reported by a Health Professional from UNITED KINGDOM on Feb 20, 2009. Male patient, 75 years of age, was diagnosed with acute myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: anaemia, bone marrow failure, chest pain What is  chest pain, chills, neutropenia, pyrexia, rash What is  rash. Evoltra dosage: unknown. Patient was hospitalized. Patient recovered.

Evoltra Side Effects Report #6074384-5
Evoltra side effect was reported by a Health Professional from UNITED KINGDOM on Jan 26, 2009. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: anaemia, chest pain What is  chest pain, chills, neutropenia, platelet count decreased, pyrexia, rash What is  rash. Evoltra dosage: unknown. Patient was hospitalized. Patient recovered.

Evoltra Side Effects Report #6127605-4
Evoltra side effect was reported by a Physician from SWEDEN on Mar 06, 2009. Male patient, child 12 years of age, was diagnosed with acute leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: abasia, balance disorder, dizziness What is  dizziness, headache What is  headache, neurotoxicity, neutropenia, nystagmus, viral infection What is  viral infection, vomiting. Evoltra dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, BACTRIM, FOLACIN, ONDASETRON, VALTREX, MORPHINE. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Evoltra